Brind.

Fifth Third Bancorp increased its stake in Dexcom by 206.0% in Q1, requiring SEC disclosure.

1 report, 1 independent Updated Jul 18

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Fifth Third Bancorp Dexcom

Keep exploring

The entities involved

Fifth Third Bancorp
American bank holding company
- PNC Financial Services Group Inc., Advisory Solutions Group LLC, and Fifth Third Bancorp purchased new investment positions on October 21, 2026.00:56
- Fifth Third Bancorp increased its holdings in the Fidelity Low Volatility Factor ETF during Q1 2026.Wed 20:30
Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems

Nothing else this week.

Related events

Surgery Partners and Fifth Third Bancorp announced increased holdings in company stock, requiring filing with the SEC on September 8, 2026.Sep 9

Coverage

Newest first; wire copies grouped

Jul 18dailypolitical.com